
Tatiana Maria Corbitt
Aug 12, 2021 - 29:31
Radio and PodcastLive Radio & Podcasts
Dr. Jennifer Gudeman is the Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals. In this episode, Dr. Gudeman and Claire discuss how Avadel Pharmaceuticals is seeking FDA approval for a once-nightly fo...
Dr. Jennifer Gudeman is an episode from Narcolepsy 360 by Claire Crisp. Dr. Jennifer Gudeman is the Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals. In this episode, Dr. Gudeman and Claire discuss how Avadel Pharmaceu...
This episode belongs to Narcolepsy 360.
Use the player on this page to stream the episode online.
Published Mar 25, 2021, 25:29 long, audio available.
Dr. Jennifer Gudeman is the Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals. In this episode, Dr. Gudeman and Claire discuss how Avadel Pharmaceuticals is seeking FDA approval for a once-nightly form of sodium oxybate (FT218) for the treatment of EDS and cataplexy in people with narcolepsy. Dr. Jennifer Gudeman was appointed Vice President, Medical and Clinical Affairs at Avadel in December 2020. Avadel is a global biopharmaceutical company committed to improving the standard of care for people with narcolepsy. Dr. Gudeman and her team are focused on publications of primary and secondary data from the phase 3 REST-ON trial of investigational once-nightly FT218 and building out the medical affairs programs. They are also leading an ongoing open-label extension clinical study, called Restore, to evaluate the long-term safety and tolerability of investigational once-nightly FT218. Dr. Gudeman has published numerous peer-reviewed papers and provided domestic and international presentations on partnership with industry for drug development. In 2017, Dr. Gudeman received the Healthcare Businesswomen's "Rising Star" award. During her career, she has led or contributed to six commercial product launches and three clinical development programs, as well as led interactions with medical societies and patient advocacy organizations to help ensure that commercial medications fulfill their clinically proven therapeutic benefits to patients and providers. Prior to joining Avadel, Dr. Gudeman was Vice President, Medical Affairs at AMAG Pharmaceuticals, overseeing a team of medical science liaisons and scientific communications. Dr. Gudeman graduated summa cum laude with a bachelor's degree in pharmacy and magna cum laude with a doctorate in pharmacy from St. Louis College of Pharmacy in 1999 and 2000, respectively. To find out more information about Avadel's Restore Study please go here . You can follow Wake Up Narcolepsy at @narcolepsy_360 on Instagram, @wakeupnarcolepsy on Instagram and Facebook and @wakenarcolepsy on Twitter. Let us know your thoughts about this episode by using the hashtag and please rate and review us on Apple Podcasts.
You can listen to Dr. Jennifer Gudeman online on Radio and Podcast. Open the player on this page to stream the available audio.
Dr. Jennifer Gudeman is an episode from Narcolepsy 360 by Claire Crisp.
This episode is 25:29 long.
This episode was published on Mar 25, 2021.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Narcolepsy 360 when more episodes are available from the podcast feed.
You can listen to Dr. Jennifer Gudeman on this page when the episode audio is available from the podcast feed.
Dr. Jennifer Gudeman is from Narcolepsy 360 by Claire Crisp.
Published Mar 25, 2021 and 25:29 long